Banner Health Children

9 Articles Matching "skyrizi"

Skyrizi vs. Cosentyx

Aug 20, 2019 , RxList
Skyrizi (risankizumab-rzaa) and Cosentyx (secukinumab) are used to treat moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Skyrizi and Cosentyx are interleukin antagonists that target different proteins. Skyrizi is an interleukin-23 antagonist and Cosentyx is an interleukin-17A...
Read more

Skyrizi vs. Enbrel

Aug 20, 2019 , RxList
Skyrizi (risankizumab-rzaa) and Enbrel (etanercept) are used to treat plaque psoriasis. Enbrel is also used to treat rheumatoid arthritis, juvenile idiopathic arthritis, and ankylosing...
Read more

Skyrizi vs. Taltz

Aug 20, 2019 , RxList
Skyrizi (risankizumab-rzaa) and Taltz (ixekizumab) are used to treat moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy....
Read more

Skyrizi vs. Simponi

Aug 20, 2019 , RxList
Skyrizi (risankizumab-rzaa) and Simponi (golimumab injection) are used to treat different types of...
Read more

Skyrizi vs. Humira

Aug 20, 2019 , RxList
Skyrizi (risankizumab-rzaa) and Humira (adalimumab) are used to treat plaque...
Read more
Demo

Skyrizi vs. Otezla

Aug 20, 2019 , RxList
Skyrizi (risankizumab-rzaa) and Otezla (apremilast) are used to treat different types of...
Read more

Stelara vs. Skyrizi

Jul 31, 2019 , RxList
Stelara (ustekinumab) Injection and Skyrizi (risankizumab-rzaa) are used to treat plaque psoriasis....
Read more

AbbVie gets FDA nod for Skyrizi

Apr 25, 2019 , Drug Store News - Retail
AbbVie's Skyrizi provides a treatment for moderate-to-severe plaque psoriasis in adults. Read More...
Read more

AbbVie's Skyrizi drug to treat psoriasis wins U.S. approval

Apr 24, 2019 , Reuters
AbbVie Inc said on Tuesday that the U.S. Food and Drug Administration approved its Skyrizi drug as a treatment for plaque psoriasis at a time when its blockbuster psoriasis drug, Humira, faces patent pressures....
Read more